The marine stakeholders demand more blue in the bioeconomy strategy

The marine biotechnology is high on the political agenda. Around 70 experts, company representatives and policy makers met at the European Parliament on March 21 to discuss what is needed for a successful European blue bioeconomy. The debate at the fully booked event revealed: the potential of the oceans is uncontested among experts, but its exploration requires close cooperation and knowledge sharing, a strong focus on sustainability, political commitment and finally, investor and consumer enthusiasm.

Continue reading

Croda acquired Canadian marine biotech company Nautilus

British multinational company Croda International Plc, specialized in the field of speciality chemicals for some of the biggest, most successful brands in the world, acquired Nautilus Biosciences Canada Inc, a technology-rich marine biotechnology company based in Charlottetown, Prince Edward Island, Canada.

Continue reading